Toyonaka, Japan

Hiroshi Nakatani

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Chemical Company, Limited. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Nakatani. Retrieved from https://idiyas.com/inventor/hiroshi-nakatani-4nyk6roy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Nakatani: Innovator in Pharmaceutical Compositions

Introduction

Hiroshi Nakatani is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address health issues such as elevated cholesterol levels.

Latest Patents

Hiroshi Nakatani holds a patent for "Pharmaceutical compositions containing fatty acid amide derivatives." This innovative composition consists of a pharmaceutically effective amount of an N-substituted fatty acid amide, which is beneficial for lowering elevated cholesterol levels in the blood. His patent showcases a complex formula that includes various aliphatic hydrocarbon chains and substituted benzyl groups, demonstrating his expertise in pharmaceutical chemistry.

Career Highlights

Nakatani is associated with Sumitomo Chemical Company, Limited, where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a positive impact on public health.

Collaborations

Throughout his career, Hiroshi Nakatani has collaborated with esteemed colleagues such as Toshitsugu Fukumaru and Noritaka Hamma. These partnerships have fostered innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Hiroshi Nakatani's contributions to pharmaceutical compositions highlight his role as a key innovator in the industry. His work continues to influence the field and improve health outcomes for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…